| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Business. Communications. Simplified. NetFortris is the provider of Communications and Network Solutions for business customers in every major industry. COVID-19 Updates.
vcpi helps compassionate care providers improve lives with outsourced IT support rooted in the unique world of senior living
Real estate data visualization, analytics, market insights. Search Manhattan, Brooklyn, NYC, apartments, condos, co-ops, townhouses, homes for sale.
Welcome to LANDESK`s home on LinkedIn! Follow us for regular tips on systems lifecycle management, endpoint security, and IT service management solutions for desktops, servers and mobile devices. Founded in 1985, LANDESK Software is the only company with proven solutions in the 4 Gartner Magic Quadrants that compose End-to-End Service Management: IT Service Desk, PC Lifecycle Configuration Management, Endpoint Protection, and Mobile Management Platforms.